483 Response Fougera Pharmaceuticals Oct 2002

Lawrence Farina FDA$119.00 - Available Now

FDA investigators audited the Fougera Pharmaceuticals - Melville, NY, United States facility and issued inspectional observation (via FDA 483) on 28 Oct 2002.

Product details

  • Category:
  • Inspection end: 28 Oct 2002
  • Location: Melville, United States
  • FEI: 2432435
Add To Cart